Price to Sales (P/S)
since 2005
Calculation
Eli Lilly & Co., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenue1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | 20.77 | = | 745.91 | ÷ | 35.91 | 35.91 | = | 34,124,100 | ÷ | 950,164,452 | |
| Feb 22, 2023 | 10.96 | = | 329.07 | ÷ | 30.03 | 30.03 | = | 28,541,400 | ÷ | 950,296,118 | |
| Feb 23, 2022 | 8.01 | = | 238.31 | ÷ | 29.74 | 29.74 | = | 28,318,400 | ÷ | 952,347,126 | |
| Feb 17, 2021 | 8.06 | = | 206.46 | ÷ | 25.60 | 25.60 | = | 24,539,800 | ÷ | 958,425,693 | |
| Feb 19, 2020 | 6.03 | = | 140.83 | ÷ | 23.34 | 23.34 | = | 22,319,500 | ÷ | 956,382,203 | |
| Feb 19, 2019 | 5.15 | = | 122.13 | ÷ | 23.72 | 23.72 | = | 24,555,700 | ÷ | 1,035,418,562 | |
| Feb 20, 2018 | 3.71 | = | 77.55 | ÷ | 20.88 | 20.88 | = | 22,871,300 | ÷ | 1,095,597,580 | |
| Feb 21, 2017 | 4.18 | = | 80.36 | ÷ | 19.23 | 19.23 | = | 21,222,100 | ÷ | 1,103,352,450 | |
| Feb 19, 2016 | 4.02 | = | 72.61 | ÷ | 18.04 | 18.04 | = | 19,958,700 | ÷ | 1,106,093,485 | |
| Feb 19, 2015 | 4.03 | = | 71.12 | ÷ | 17.65 | 17.65 | = | 19,615,600 | ÷ | 1,111,103,942 | |
| Feb 19, 2014 | 2.81 | = | 58.09 | ÷ | 20.64 | 20.64 | = | 23,113,100 | ÷ | 1,119,713,084 | |
| Feb 21, 2013 | 2.71 | = | 54.02 | ÷ | 19.93 | 19.93 | = | 22,603,400 | ÷ | 1,134,411,762 | |
| Feb 24, 2012 | 1.87 | = | 39.05 | ÷ | 20.93 | 20.93 | = | 24,286,500 | ÷ | 1,160,406,840 | |
| Feb 22, 2011 | 1.73 | = | 34.43 | ÷ | 19.93 | 19.93 | = | 23,076,000 | ÷ | 1,157,664,779 | |
| Feb 22, 2010 | 1.82 | = | 34.47 | ÷ | 18.94 | 18.94 | = | 21,836,000 | ÷ | 1,153,145,432 | |
| Feb 27, 2009 | 1.66 | = | 29.38 | ÷ | 17.74 | 17.74 | = | 20,378,000 | ÷ | 1,149,015,882 | |
| Feb 29, 2008 | 3.05 | = | 50.02 | ÷ | 16.39 | 16.39 | = | 18,633,500 | ÷ | 1,136,985,018 | |
| Feb 28, 2007 | 3.80 | = | 52.59 | ÷ | 13.84 | 13.84 | = | 15,691,000 | ÷ | 1,134,034,234 | |
| Mar 1, 2006 | 4.31 | = | 55.89 | ÷ | 12.96 | 12.96 | = | 14,645,300 | ÷ | 1,129,982,580 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Eli Lilly & Co. Annual Report.
Comparison to Competitors
Eli Lilly & Co., P/S, long-term trends, comparison to competitors
| Eli Lilly & Co. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | 20.77 | 5.72 | 5.78 | 2.19 | 7.76 | 3.40 | 4.43 | 5.43 | 5.52 | 2.66 | 7.84 | 4.99 |
| Feb 22, 2023 | 10.96 | 4.61 | 5.17 | 3.29 | 5.79 | 3.86 | 4.34 | 4.71 | 2.92 | 2.37 | 7.01 | 4.73 |
| Feb 23, 2022 | 8.01 | 4.53 | 5.10 | 3.16 | 6.37 | 2.85 | 4.66 | 3.96 | 3.45 | 3.18 | 4.20 | 5.39 |
| Feb 17, 2021 | 8.06 | 4.05 | 5.64 | 3.16 | 7.01 | 3.24 | 5.15 | 3.93 | 309.64 | 4.50 | 6.24 | 5.52 |
| Feb 19, 2020 | 6.03 | 4.22 | 6.03 | 5.52 | 6.29 | 4.00 | 4.79 | 4.33 | — | 3.66 | 5.34 | 4.83 |
| Feb 19, 2019 | 5.15 | 3.58 | 5.22 | 3.67 | 3.97 | 3.84 | 4.45 | 4.92 | — | 4.49 | 6.62 | 4.24 |
| Feb 20, 2018 | 3.71 | 6.67 | 5.82 | 5.02 | 3.70 | 4.10 | 4.56 | 3.68 | — | 4.05 | 5.92 | 4.01 |
| Feb 21, 2017 | 4.18 | 3.84 | 5.65 | 4.72 | 3.48 | 3.08 | 4.62 | 4.54 | — | 3.84 | 7.86 | 3.37 |
| Feb 19, 2016 | 4.02 | 3.83 | 5.28 | 6.07 | 2.91 | 3.80 | 4.13 | 3.56 | — | 3.76 | 9.38 | 3.05 |
| Feb 19, 2015 | 4.03 | 4.90 | 6.13 | 6.28 | 3.09 | 6.36 | 3.77 | 3.93 | — | 4.24 | 14.62 | 3.06 |
| Feb 19, 2014 | 2.81 | 4.31 | 5.22 | 5.48 | 2.78 | 11.95 | 3.63 | 3.78 | — | 3.97 | 15.52 | 3.74 |
| Feb 21, 2013 | 2.71 | 3.30 | 4.09 | 3.40 | 2.32 | 6.95 | 3.17 | 2.73 | — | 3.34 | 11.66 | 2.12 |
| Feb 24, 2012 | 1.87 | — | 3.52 | 2.63 | 2.28 | 4.22 | 2.75 | 2.43 | — | 2.37 | 20.90 | 1.77 |
| Feb 22, 2011 | 1.73 | — | 3.32 | 2.23 | 2.48 | 4.19 | 2.65 | 2.18 | — | 2.27 | 7.38 | 2.00 |
| Feb 22, 2010 | 1.82 | — | 3.88 | 2.27 | 2.16 | 6.64 | 2.82 | 4.23 | — | 2.83 | 5.74 | 1.98 |
| Feb 27, 2009 | 1.66 | — | 3.44 | 1.96 | 1.30 | 8.03 | 2.37 | 2.14 | — | 1.72 | 5.17 | 1.44 |
| Feb 29, 2008 | 3.05 | — | 3.46 | 2.30 | 2.16 | 10.90 | 2.95 | 4.04 | — | 3.11 | 11.94 | 2.40 |
| Feb 28, 2007 | 3.80 | — | 5.41 | 3.07 | 2.30 | 12.67 | 3.53 | 4.23 | — | 3.67 | 19.70 | 5.05 |
| Mar 1, 2006 | 4.31 | — | 7.24 | 2.34 | 2.40 | 15.36 | 3.49 | 3.50 | — | 3.77 | 14.06 | 2.15 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Eli Lilly & Co., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Eli Lilly & Co. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 21, 2024 | 20.77 | 5.78 |
| Feb 22, 2023 | 10.96 | 4.44 |
| Feb 23, 2022 | 8.01 | 4.42 |
| Feb 17, 2021 | 8.06 | 5.00 |
| Feb 19, 2020 | 6.03 | 4.79 |
| Feb 19, 2019 | 5.15 | 4.46 |
| Feb 20, 2018 | 3.71 | 4.51 |
| Feb 21, 2017 | 4.18 | 4.24 |
| Feb 19, 2016 | 4.02 | 4.05 |
| Feb 19, 2015 | 4.03 | 4.46 |
| Feb 19, 2014 | 2.81 | 4.25 |
| Feb 21, 2013 | 2.71 | 3.24 |
| Feb 24, 2012 | 1.87 | 2.56 |
| Feb 22, 2011 | 1.73 | 2.41 |
| Feb 22, 2010 | 1.82 | 2.96 |
| Feb 27, 2009 | 1.66 | 2.20 |
| Feb 29, 2008 | 3.05 | 3.18 |
| Feb 28, 2007 | 3.80 | 3.87 |
| Mar 1, 2006 | 4.31 | 3.82 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Eli Lilly & Co., P/S, long-term trends, comparison to industry (health care)
| Eli Lilly & Co. | Health Care | |
|---|---|---|
| Feb 21, 2024 | 20.77 | 2.30 |
| Feb 22, 2023 | 10.96 | 33,191.58 |
| Feb 23, 2022 | 8.01 | 2.28 |
| Feb 17, 2021 | 8.06 | 2.25 |
| Feb 19, 2020 | 6.03 | 2.13 |
| Feb 19, 2019 | 5.15 | 2.33 |
| Feb 20, 2018 | 3.71 | 2.30 |
| Feb 21, 2017 | 4.18 | 2.12 |
| Feb 19, 2016 | 4.02 | 2.10 |
| Feb 19, 2015 | 4.03 | 2.38 |
| Feb 19, 2014 | 2.81 | 2.17 |
| Feb 21, 2013 | 2.71 | 1.73 |
| Feb 24, 2012 | 1.87 | 1.55 |
| Feb 22, 2011 | 1.73 | 1.46 |
| Feb 22, 2010 | 1.82 | 1.64 |
| Feb 27, 2009 | 1.66 | 1.36 |
| Feb 29, 2008 | 3.05 | 2.01 |
| Feb 28, 2007 | 3.80 | 2.43 |
| Mar 1, 2006 | 4.31 | 2.72 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).